ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-28 Cr | ₹46 Cr | ₹11 Cr | ₹40 Cr | ₹37 Cr |
What is the latest Cash Flow from Operating Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-28 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹37 Cr |
How is Cash Flow from Operating Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-28 Cr | Negative | |
| Mar2024 | ₹46 Cr | 332.73 | |
| Mar2023 | ₹11 Cr | -73.98 | |
| Mar2022 | ₹40 Cr | 10.38 | |
| Mar2021 | ₹37 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹417.0 Cr | -3.1% | -3.4% | -43.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -3.1% |
-3.4% |
-43.6% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses